Everything here is written for AgeMD's formulation: Semaglutide/Glycine/B12 (5 mg/5 mg/1 mg per mL) , compounded by an FDA-registered pharmacy
As interest in GLP-1s continues to grow, from metabolic disorders to potential use in addiction or Alzheimers, theres a chance for manufacturers to step up with next-generation formulations that balance efficacy, accessibility, and regulatory rigor
By Dr Moxit Shah,Endocrinologist In Ahmedabad With the arrival of Mounjaro, Ozempic, Wegovy, and multiple generic semaglutide brands in India, patients now have more treatment options than ever before for diabetes, obesity, and weight loss
And in April 2025, the FDA cited failures to monitor areas where sterile drugs are prepared and inadequate equipment sterilization